United Therapeutics | UTHR - Dochód Netto

Cena Akcji
572.85
Dzienna Zmiana
3.74 0.66%
Miesięcznie
-2.64%
Rocznie
89.00%
Q2 Prognozy TE
555.02




Dochód Netto Zmiana Data
Amarin USD -1.22M 6.51M 2025-12
Ardelyx USD -407K 562K 2025-12
Baxter International USD -1.13B 1.08B 2025-12
Bayer EUR -3.76B 2.79B 2025-12
BioCryst Pharmaceuticals USD 245.84M 232.95M 2025-12
Biogen USD 319.5M 368.4M 2026-03
BioMarin Pharmaceutical USD -46.57M 15.83M 2025-12
Emergent BioSolutions USD -261.3M 78.3M 2023-06
Esperion Therapeutics USD 61.83M 93.16M 2025-12
Gilead Sciences USD 2.18B 869M 2025-12
GlaxoSmithKline GBP 1.74B 1.1B 2026-03
Halozyme Therapeutics USD -141.59M 316.82M 2025-12
Insmed USD -328.48M 41.54M 2025-12
Ionis Pharmaceuticals USD -93M 136M 2026-03
J&J USD 5.24B 119M 2026-03
Lexicon Pharmaceuticals USD -15.53M 2.76M 2025-12
Moderna USD -200M 625M 2025-09
Omeros USD -32.23M 23.81M 2024-09
Pfizer USD -1.65B 5.19B 2025-12
PTC Therapeutics USD -134.96M 150.86M 2025-12
Regeneron Pharmaceuticals USD 844.6M 615.4M 2025-12
Sangamo BioSciences USD -36.13M 12.96M 2024-06
Sarepta Therapeutics USD -412.23M 232.28M 2025-12
Teva Pharmaceutical Industries USD 369M 111M 2026-03
United Therapeutics USD 364.3M 25.6M 2025-12
Vertex Pharmaceuticals USD 1.19B 108.2M 2025-12